JPMorgan Chase & Co. has disclosed a major holding increase in Bodycote plc (BOY), the UK-listed specialist heat treatment and thermal processing services company, after its combined voting rights position crossed a reporting threshold on 23 October 2026. The notification, filed with the issuer on 27 October 2026, reveals JPMorgan's total position reached 11.117131% of Bodycote's voting rights, up from a previously notified 10.530870%. The disclosure, made under DTR5 transparency rules, reflects both direct share holdings and a substantial portfolio of cash-settled equity swaps held across multiple JPMorgan entities. Investors in Bodycote will be watching the composition and scale of this institutional position closely.

Key Points

  • Bodycote plc (BOY), UK-listed specialist in heat treatment and thermal processing services
  • JPMorgan Chase & Co. disclosed a combined voting rights position of 11.117131% in Bodycote following a threshold crossing on 23 October 2026
  • Total voting rights held: 18,920,018; direct shares: 4,823,916 (2.834463%); financial instruments: 14,096,102 (8.282668%)
  • Investors should monitor whether further threshold crossings or position changes are disclosed in subsequent TR-1 filings

JPMorgan's Combined Bodycote Position Rises from 10.53% to 11.12% at Threshold Date

According to the TR-1 standard notification form, JPMorgan Chase & Co.'s total position in Bodycote plc stood at 11.117131% as of 23 October 2026, comprising 2.834463% in voting rights attached directly to shares and 8.282668% held through financial instruments. The previous notification recorded a combined position of 10.530870%, meaning the aggregate stake increased by approximately 0.586 percentage points. The total number of voting rights associated with this position is stated as 18,920,018. The notification was completed in London on 27 October 2026, four days after the threshold was crossed, in line with standard regulatory disclosure timelines under the UK's Disclosure Guidance and Transparency Rules.

Cash-Settled Equity Swaps Account for the Majority of JPMorgan's Bodycote Exposure

The disclosure reveals that 8.282668% of JPMorgan's total 11.117131% position in Bodycote is held through cash-settled equity swaps, classified under DTR5.3.1R.(1)(b) as financial instruments with similar economic effect to shareholdings. These swaps, totalling 14,096,102 voting rights, carry a range of expiration dates extending from late October 2026 through to December 2027, with the largest individual positions including swaps expiring on 29 July 2027 (2,600,756 voting rights) and 16 June 2027 (2,367,294 voting rights). Because these instruments are cash-settled rather than physically settled, they do not automatically convert into direct share ownership upon exercise or expiry.

J.P. Morgan Securities PLC Named as Key Subsidiary Holding Bodycote Instruments

The notification identifies J.P. Morgan Securities PLC as the principal subsidiary through which financial instruments in Bodycote are effectively held, with JPMorgan Chase & Co. listed as the ultimate controlling entity. The full chain of controlled undertakings disclosed in the announcement includes JPMorgan Chase Bank, National Association, J.P. Morgan International Finance Limited, and J.P. Morgan Capital Holdings Limited, each held at 100% by the parent. Additional subsidiaries named include J.P. Morgan SE and J.P. Morgan Markets Limited. Bodycote plc, incorporated in the UK with ISIN GB00B3FLWH99, provides specialist thermal processing services to industrial customers across international markets.